Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome

BACKGROUND: Down syndrome (DS) may be considered a genetic form of Alzheimer’s disease (AD) due to universal development of AD neuropathology, but diagnosis and treatment trials are hampered by a lack of reliable blood biomarkers. A potential biomarker is neurofilament light (NF-L), due to its assoc...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Alzheimers Res Ther
Huvudupphovsmän: Strydom, Andre, Heslegrave, Amanda, Startin, Carla M., Mok, Kin Y., Hardy, John, Groet, Jurgen, Nizetic, Dean, Zetterberg, Henrik
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2018
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5891918/
https://ncbi.nlm.nih.gov/pubmed/29631614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0367-x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk